Plasma apolipoprotein H limits HCV replication and associates with response to NS3 protease inhibitors‐based therapy

E-ISSN： 1478-3231|35|7|1833-1844

ISSN： 1478-3223

Source： LIVER INTERNATIONAL (ELECTRONIC), Vol.35, Iss.7, 2015-07, pp. : 1833-1844

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Transcriptional Response of MxA, PKR and SOCS3 to Interferon-Based Therapy in HCV Genotype 4-Infected Patients and Contribution of p53 to Host Antiviral Response

Intervirology, Vol. 55, Iss. 3, 2011-05 ,pp. : 210-218

Karger

Access to resources Recommend Favorite

Interleukin‐ 28B: a prognostic marker in interferon based therapy of chronic HCV patients of the Pakistan with variable treatment response

APMIS (ELECTRONIC), Vol. 123, Iss. 9, 2015-09 ,pp. : 765-771

John Wiley & Sons Inc

Access to resources Recommend Favorite

Baseline sensitivity of T cells to alpha‐IFN correlates with sustained virological response to IFN‐based triple therapy in HCV infection

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. 6, 2015-06 ,pp. : 524-534

John Wiley & Sons Inc

Access to resources Recommend Favorite

First Report on the Validated Classification-Based Chemometric Modeling of Human Rhinovirus 3C Protease (HRV 3Cpro) Inhibitors

International Journal of Quantitative Structure-Property Relationships (IJQSPR)*, Vol. 3, Iss. 2, 2018-07 ,pp. : 1-20

IGI Global_journal

Access to resources Recommend Favorite

Ritonavir-boosted protease inhibitors in HIV therapy

By Hull Mark W. Montaner Julio S. G.

Annals of Medicine, Vol. 43, Iss. 5, 2011-08 ,pp. : 375-388

Informa Healthcare

Access to resources Recommend Favorite